Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Open-Labeled Study of Prophylactic Vs. Therapeutic Use of Uroxatrol to Determine Improvements in Urinary Morbidity Following Men Undergoing Prostate Brachytherapy

NCT00201630 is registered in ClinicalTrials.gov with New York Prostate Institute as lead sponsor.

NCT NCT00201630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00201630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Open-Labeled Study of Prophylactic Vs. Therapeutic Use of Uroxatrol to Determine Improvements in Urinary Morbidity Following Men Undergoing Prostate Brachytherapy
Lead sponsor
New York Prostate Institute
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2005
Completion date
September 30, 2005
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer